IDERA PHARMACEUTICALS INC (IDRA)
US45168K4058 - Common Stock
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -16.70M | 98.09M | -112.66M | -56.52M | -59.88M | |||
| Depreciation Amortization | 16.00K | 22.00K | 60.00K | 120.00K | 430.00K | |||
| Change In Working Capital | 5.35M | 388.00K | -1.12M | -3.26M | 1.29M | |||
| Interest Paid | 0.00 | 5.00K | 0.00 | 0.00 | 10.00K | |||
| Other non cash items | 2.04M | -123.10M | 79.95M | 15.15M | 6.25M | |||
| OPERATING CASH FLOW | -15.34M | -24.60M | -33.77M | -44.50M | -51.92M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -10.00K | -10.00K | -80.00K | |||
| Other Investing Activity | 5.48M | 4.50M | -1.68M | -2.39M | 290.00K | |||
| INVESTING CASH FLOW | 5.48M | 4.50M | -1.69M | -2.40M | 220.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -435.00K | -220.00K | -10.00K | -220.00K | |||
| Stock Issued/Repurchased | 54.00K | 19.85M | 28.89M | 5.42M | 10.41M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | 0.00 | N/A | 10.07M | N/A | |||
| FINANCING CASH FLOW | 54.00K | 19.41M | 28.67M | 15.49M | 10.19M | |||
| CHANGE IN CASH | -9.81M | -684.00K | -6.79M | -31.41M | -41.51M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -15.34M | -24.60M | -33.77M | -44.50M | -51.92M | |||
| Capital Expenditure | N/A | 0.00 | -10.00K | -10.00K | -80.00K | |||
| FREE CASH FLOW | -15.34M | -24.60M | -33.78M | -44.51M | -52.00M | |||
All data in USD